Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 15, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Left Ventricular Hypertrophy
Interventions
BEHAVIORAL

Customized discharge and expedited referral instructions

The intervention for subjects with LVH on research POCUS will consist of three elements: 1) disclosure of presence of LVH to subject, ED team and primary care physician (PCP) (if applicable); 2) educational discharge instructions describing high BP, HTN, LVH, implications for development of cardiovascular disease (such as development of heart failure, stroke), options for treatment (lifestyle, medications) and importance of follow-up; A preliminary version will be refined prior to the start of the trial by feedback from ED physicians and patients. Refinement will target content, phrasing, and literacy level. 3) referral to outpatient care, consisting of one of two options, based on whether the subject has an established PCP. For subjects with existing PCP, the study team will call the office, inform about study participation, LVH findings, and secure a follow-up appointment. For those with no PCP, study team will arrange for follow-up to special clinic.

Trial Locations (1)

06512

RECRUITING

Yale New Haven Hospital, New Haven

All Listed Sponsors
collaborator

Robert E. Leet and Clara Guthrie Patterson Trust

UNKNOWN

lead

Yale University

OTHER